Phreesia (NYSE:PHR) Receives Outperform Rating from Royal Bank Of Canada

Phreesia (NYSE:PHR)‘s stock had its “outperform” rating reaffirmed by equities researchers at Royal Bank Of Canada in a research report issued to clients and investors on Thursday, Benzinga reports. They presently have a $19.00 price objective on the stock. Royal Bank Of Canada’s target price would indicate a potential upside of 70.11% from the stock’s previous close.

PHR has been the subject of several other reports. Wells Fargo & Company set a $10.00 price target on shares of Phreesia and gave the company an “equal weight” rating in a research report on Thursday. DA Davidson reiterated a “buy” rating and set a $14.00 price target on shares of Phreesia in a report on Thursday, May 28th. Piper Sandler cut shares of Phreesia from an “overweight” rating to a “neutral” rating and set a $12.00 price objective on the stock. in a research note on Thursday, May 28th. Truist Financial increased their price objective on Phreesia from $11.00 to $12.00 and gave the company a “hold” rating in a report on Thursday, May 28th. Finally, Wall Street Zen raised Phreesia from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Nine equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $16.29.

Phreesia Trading Down 5.7%

Shares of PHR stock traded down $0.68 during mid-day trading on Thursday, reaching $11.17. 168,073 shares of the stock traded hands, compared to its average volume of 1,492,030. The stock’s fifty day simple moving average is $11.19 and its two-hundred day simple moving average is $10.48. Phreesia has a 1-year low of $7.77 and a 1-year high of $31.38. The company has a market cap of $690.36 million, a price-to-earnings ratio of 74.30 and a beta of 0.86. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.41.

Phreesia (NYSE:PHR) last released its quarterly earnings data on Wednesday, September 2nd. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.06). The firm had revenue of $129.46 million during the quarter, compared to analyst estimates of $129.06 million. Phreesia had a net margin of 1.85% and a return on equity of 5.13%. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.01 EPS. On average, research analysts anticipate that Phreesia will post 0.39 EPS for the current fiscal year.

Institutional Investors Weigh In On Phreesia

Several large investors have recently added to or reduced their stakes in the business. EverSource Wealth Advisors LLC increased its holdings in Phreesia by 1,119.8% in the first quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock worth $27,000 after purchasing an additional 3,001 shares in the last quarter. Van ECK Associates Corp grew its position in shares of Phreesia by 78.7% during the 4th quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock worth $42,000 after buying an additional 1,102 shares during the period. New York State Teachers Retirement System acquired a new stake in shares of Phreesia during the 1st quarter worth approximately $44,000. Rockefeller Capital Management L.P. increased its stake in shares of Phreesia by 354.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock valued at $47,000 after acquiring an additional 2,149 shares in the last quarter. Finally, Allworth Financial LP bought a new stake in shares of Phreesia in the 2nd quarter valued at $58,000. Institutional investors and hedge funds own 92.10% of the company’s stock.

Key Stories Impacting Phreesia

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Management maintained fiscal 2027 revenue guidance of $510 million to $520 million, broadly in line with Wall Street expectations, reducing the risk of a near-term outlook cut. Phreesia maintains FY2027 revenue outlook
• Positive Sentiment: Phreesia reported positive operating and free cash flow for the quarter and reduced debt principal by more than $23 million, supporting balance-sheet improvement and potentially lowering future interest costs. Phreesia Announces Second Quarter Fiscal 2027 Results
• Positive Sentiment: Management identified AccessOne as a multi-year growth opportunity, giving investors an additional potential driver beyond the company’s core revenue expansion. Needham & Company also initiated or reiterated a Buy rating, adding analyst support. Needham Buy Rating
• Neutral Sentiment: The quarter’s revenue growth and profitability expansion were described as in line with expectations, suggesting execution remains steady but did not produce a major upside surprise. Phreesia Q2 2027 Earnings Call Transcript
• Negative Sentiment: Adjusted earnings were materially below consensus at $0.03 per share versus the expected $0.09-$0.11. The miss may limit upside for PHR despite the revenue beat and maintained full-year outlook. Phreesia Q2 Earnings and Revenues Lag Estimates

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.